NCT05519007

Brief Summary

A prospective, single-site, double-arm, parallel, interventional, randomized, controlled clinical trial to assess 90-day rate of joint infections in subjects undergoing primary hip replacements after administration of Next Science No-Rinse Solution (hereby referred to as NS) vs SOC (saline irrigation). The Next Science treatment arm will exhibit greater reduction in rate of 90-day post-operative joint infection than SOC (saline) arm

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
936

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Sep 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Sep 2023Dec 2026

First Submitted

Initial submission to the registry

August 25, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 29, 2022

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 26, 2023

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 23, 2025

Status Verified

May 1, 2025

Enrollment Period

3.3 years

First QC Date

August 25, 2022

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • infection rate

    Joint infection rate after surgery

    at 90 days

Secondary Outcomes (1)

  • QT prolongation

    up to 24 hours (from the time of irrigation to closure)

Study Arms (2)

The Next Science treatment

EXPERIMENTAL

The surgical site will be irrigated with NS prior to closure, which will be suctioned at the end of the treatment time

Other: No-Rinse Solution (NS)

Standard of Care

ACTIVE COMPARATOR

Saline irrigation

Other: Saline irrigation

Interventions

The surgical site will be irrigated with NS prior to closure,

The Next Science treatment

The surgical site will be irrigated with Saline

Standard of Care

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adult that meets at least one of the below criteria at time of screening:
  • American Society of Anesthesiologists (ASA) 3 2
  • BMI \>35
  • Patient with functional limitations as a result of disease1:
  • Poorly treated hypertension
  • Poorly treated diabetes
  • Chronic renal failure
  • Bronchospastic disease
  • Disease with intermittent exacerbations
  • Stable angina
  • Implanted pacemaker
  • Known history as an active nicotine use (smoker)
  • Known history of uncontrolled diabetes mellitus (HgbA1C \> 7.0)
  • Known history of end stage organ disease
  • Known history of inflammatory arthritis and currently on rheumatological medication (DMARDs)
  • +8 more criteria

You may not qualify if:

  • Unable to provide signed and dated informed consent.
  • Unable or unwilling to comply with all study-related procedures.
  • Known history of allergic reaction to any of the study products or its components, including any products used for standard of care (such as dressings or any coverings)
  • Subject has contraindications to general anesthesia
  • Any subject positive for Covid-19 virus at time of surgical screening
  • Subjects have evidence of prolonged QT segment, per EKG.
  • Subjects from a vulnerable population, in accordance with 45 CFR 46 Subparts B, C, and D

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

North Shore University Hospital

Manhasset, New York, 11030, United States

RECRUITING

Long Island Jewish Medical Center

New Hyde Park, New York, 11040, United States

RECRUITING

Lenox Hill Hospital

New York, New York, 10075, United States

RECRUITING

Related Publications (4)

  • Gronbeck C, Cote MP, Lieberman JR, Halawi MJ. Risk stratification in primary total joint arthroplasty: the current state of knowledge. Arthroplast Today. 2019 Feb 5;5(1):126-131. doi: 10.1016/j.artd.2018.10.002. eCollection 2019 Mar.

    PMID: 31020036BACKGROUND
  • Doyle DJ, Goyal A, Bansal P, et al. American Society of Anesthesiologists Classification. [Updated 2020 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441940/

    BACKGROUND
  • Moonesinghe SR, Mythen MG, Das P, Rowan KM, Grocott MP. Risk stratification tools for predicting morbidity and mortality in adult patients undergoing major surgery: qualitative systematic review. Anesthesiology. 2013 Oct;119(4):959-81. doi: 10.1097/ALN.0b013e3182a4e94d.

    PMID: 24195875BACKGROUND
  • Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY, Cohen ME. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013 Nov;217(5):833-42.e1-3. doi: 10.1016/j.jamcollsurg.2013.07.385. Epub 2013 Sep 18.

    PMID: 24055383BACKGROUND

Study Officials

  • Giles Scuderi

    Northwell Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopaedic Surgery, Joint Reconstruction

Study Record Dates

First Submitted

August 25, 2022

First Posted

August 29, 2022

Study Start

September 26, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 23, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations